PALO ALTO, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. announced today that company management will present a corporate overview at an upcoming investor conference.
After the presentation, the slides may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. The slides will be available on the site for two weeks following the presentation.
CONTACT: Willie Quinn, Executive Director, Corporate Development of Jazz
Pharmaceuticals, Inc., investorinfo@jazzpharmaceuticals.com; or Karen L.
Bergman, +1-650-575-1509, or Michelle Corral, +1-415-794-8662, both of BCC
Partners for Jazz Pharmaceuticals, Inc.
Web site: http://www.jazzpharmaceuticals.com/
